Abstract: The invention relates to a process for producing a composite material for wound dressings, comprising the following steps: (I) providing a first film, having a first film surface and a second film surface running virtually parallel to the first film surface: (II) mixing an NCO-terminated polyurethane prepolymer with at least water to give a polyurethane prepolymer/water mixture, (III) applying the polyurethane prepolymer/water mixture to at least one part of the first film surface to form a layer, the layer having a first layer surface which is in contact with the first film via at least one part of the first film surface, and having a second layer surface which runs virtually parallel to the first layer surface; (IV) covering at least one part of the second layer surface with a further film, wherein the bond strength between the first film and the layer and also between the layer and the further film is greater in each case than the tensile strain at break of the layer.

Abstract: The present invention relates to a composition, a process for its production, and use thereof. The composition comprises water, a polyurethane polymer and a water-soluble salt of a chelating agent, said polyurethane polymer having a hydrolyzable group, said polyurethane polymer is a reaction product comprising the following reactive components: Component A) an isocyanate, Component B) a compound having an isocyanate-reactive group, wherein said compound comprises at least one group that can be converted to said hydrolyzable group, optionally Component C) an emulsifier, optionally Component D) a solvent, and optionally Component E) a reactive diluent; wherein said water-soluble salt of the chelating agent is present in an amount of from 0.04 to 1.8% by weight, relative to 100% by weight of said polyurethane polymer.

Abstract: The invention relates to a method for producing a cosmetic composition, comprising at least one polyurethane urea which does not contain any ionically hydrophilizing groups and is dissolved in a solvent or solvent mixture, wherein the solvent consists of one or more monohydroxy-functional alcohol(s), or a solvent mixture that consists of organic solvents and contains ?50 wt. %, relative to the total weight of the solvent mixture, of at least one monohydroxy-functional alcohol. The invention also relates to a cosmetic composition obtainable according to the method of the invention as well as to a method for forming a cosmetic coating on skin, nails and/or keratin fibers using the cosmetic compositions of the invention. The invention further relates to a sunscreen composition containing a polyurethane urea as well as to said sunscreen composition for protecting skin and/or hair from negative effects of sun rays.

Abstract: The present invention relates to aqueous, curable composition, comprising or consisting of A) at least one uretdione prepolymer, which comprises at least one uretdione group, and which is obtainable by reacting A1) at least one uretdione polyisocyanate having an isocyanate functionality of at least 2.0, whereby said uretdione polyisocyanate is obtained from at least one aliphatic polyisocyanate, with A2) at least one compound comprising at least one Zerewitinoff-active group, and A3) at least one reactant, which comprises at least one Zerewitinoff-active group and being different from A2 or which is H2O, preferably in the presence of at least one catalyst, to obtain the uretdione prepolymer, wherein the prepolymer has an acid number of at most 4 mg KOH/g, preferably determined according to DIN EN ISO 2114:2002-06 as 37 wt. % aqueous dispersion; and B) optionally at least one compound, which comprises at least one Zerewitinoff-active group; and C) at least one azolate-compound.

Abstract: The invention provides a process for producing polyurethane foams, in which compositions comprising A) isocyanate-functional prepolymers obtainable by the reaction of A1) low molecular weight diisocyanates of molar mass from 140 to 278 g/mol with A2) polyalkylene oxides having an OH functionality of two or more, A3) optionally further isocyanate-reactive components not covered by A2), B) water in an amount of at least 2% by weight, based on the total weight of the composition; C) optionally heterocyclic 4-membered or 6-membered ring oligomers of low molecular weight diisocyanates having a molar mass of 140 to 278 g/mol; D) optionally catalysts; E) optionally salts of weak acids, the corresponding free acids of which have a pKA in water at 25° C. of ?3.0 and ?14.

Abstract: The invention relates to a contact adhesive product, comprising a substrate and a polyurethane resin, which can be obtained by reacting at least A) an aliphatic polyisocyanate component having an average isocyanate functionality of ?1.8 and ?2.

Abstract: The present invention relates to a method that includes providing a formulation having an isocyanate-functional prepolymer and a curing component comprising an amino-functional aspartic ester of the general formula (I) applying the formulation to a cell tissue; and curing the formulation such that the loss of blood (haemostatic) or tissue fluids is staunched or leaks in cell tissues are sealed.

Abstract: The present invention relates to a composition, a process for its production, and use thereof. The composition comprises water, a polyurethane polymer and a water-soluble salt of a chelating agent, said polyurethane polymer having a hydrolyzable group, said polyurethane polymer is a reaction product comprising the following reactive components: Component A) an isocyanate, Component B) a compound having an isocyanate-reactive group, wherein said compound comprises at least one group that can be converted to said hydrolyzable group, optionally Component C) an emulsifier, optionally Component D) a solvent, and optionally Component E) a reactive diluent; said water-soluble salt of the chelating agent is present in an amount of from 0.04 to 1.

Abstract: The invention relates to a process for producing a composite material for wound dressings, comprising the following steps: (I) providing a first film, having a first film surface and a second film surface running virtually parallel to the first film surface; (II) mixing an NCO-terminated polyurethane prepolymer with at least water to give a polyurethane prepolymer/water mixture, (III) applying the polyurethane prepolymer/water mixture to at least one part of the first film surface to form a layer, the layer having a first layer surface which is in contact with the first film via at least one part of the first film surface, and having a second layer surface which runs virtually parallel to the first layer surface; (IV) covering at least one part of the second layer surface with a further film, wherein the bond strength between the first film and the layer and also between the layer and the further film is greater in each case than the tensile strain at break of the layer.

Abstract: The present invention relates to a method that includes providing a formulation having an isocyanate-functional prepolymer and a curing component comprising an amino-functional aspartic ester of the general formula (I) applying the formulation to a cell tissue; and curing the formulation such that the loss of blood (haemostatic) or tissue fluids is staunched or leaks in cell tissues are sealed.

Abstract: The invention relates to a contact adhesive product, comprising a substrate and a polyurethane resin, which can be obtained by reacting at least A) an aliphatic polyisocyanate component having an average isocyanate functionality of ?1.8 and ?2.

Abstract: The use of a foam comprising polyurethane for cosmetic applications is provided. Process for applying a cosmetic component to a skin via the foam and a process for cleaning a part of a skin via the foam are provided too. An applicator as well as an envelope and a layered structure comprising the foam are shown.

Abstract: The present invention relates to aqueous, curable composition, comprising or consisting of A) at least one uretdione prepolymer, which comprises at least one uretdione group, and which is obtainable by reacting A1) at least one uretdione polyisocyanate having an isocyanate functionality of at least 2.0, whereby said uretdione polyisocyanate is obtained from at least one aliphatic polyisocyanate, with A2) at least one compound comprising at least one Zerewitinoff-active group, and A3) at least one reactant, which comprises at least one Zerewitinoff-active group and being different from A2 or which is H2O, preferably in the presence of at least one catalyst, to obtain the uretdione prepolymer, wherein the prepolymer has an acid number of at most 4 mg KOH/g, preferably determined according to DIN EN ISO 2114:2002-06 as 37 wt. % aqueous dispersion; and B) optionally at least one compound, which comprises at least one Zerewitinoff-active group; and C) at least one azolate-compound.

Abstract: The present invention relates to a method that includes providing a formulation having an isocyanate-functional prepolymer and a curing component comprising an amino-functional aspartic ester of the general formula (I) applying the formulation to a cell tissue; and curing the formulation such that the loss of blood (haemostatic) or tissue fluids is staunched or leaks in cell tissues are sealed.

Abstract: The invention relates to an adhesive that can be produced from an aqueous polyurethane urea dispersion, containing an amorphous polyurethane urea, which can be obtained by reacting at least A) an aliphatic polyisocyanate component having an average isocyanate functionality of ?1.8 and ?2.

Abstract: The invention relates to a method for coating textiles and/or leather, comprising applying at least one polyurethane urea dissolved in a solvent or solvent mixture, wherein the solvent consists of one or more monohydroxy-functional alcohols, or a solvent mixture consisting of organic solvents, containing >80 wt. % of at least one monohydroxy-functional alcohol in relation to the total mass of the solvent mixture is used, and wherein the polyurethane urea is formed by: a) at least one araliphatic, aliphatic and/or cycloaliphatic diisocyanate; b) at least one polyether polyol having a number average molecular weight Mn?400 and ?6000 g/mol and an average hydroxyl functionality of ?1.5 and ?4; c) at least one amino-functional compound having at least two isocyanate reactive amino groups; and optionally other components.

Abstract: The invention provides a process for producing polyurethane foams, the foams thus produced and the uses thereof. In the inventive process compositions comprising A) isocyanate-functional prepolymers obtainable by the reaction of A1) aliphatic, low molecular weight diisocyanates of molar mass from 140 to 278 g/mol with A2) polyalkylene oxides having an OH functionality of two or more, A3) optionally further isocyanate-reactive components not covered by A2), B) water in an amount of at least 2% by weight, based on the total weight of the composition; C) optionally heterocyclic 4-membered or 6-membered ring oligomers of low molecular weight, aliphatic diisocyanates having a molar mass of 140 to 278 g/mol; D) optionally catalysts; E) optionally salts of weak acids, the corresponding free acids of which have a pKA in water at 25° C. of ?3.0 and ?14.

Abstract: The invention provides a process for producing polyurethane foams, the foams thus produced and the uses thereof. In the inventive process compositions comprising A) isocyanate-functional prepolymers obtainable by the reaction of A1) aliphatic, low molecular weight diisocyanates of molar mass from 140 to 278 g/mol with A2) polyalkylene oxides having an OH functionality of two or more, A3) optionally further isocyanate-reactive components not covered by A2), B) water in an amount of at least 2% by weight, based on the total weight of the composition; C) optionally heterocyclic 4-membered or 6-membered ring oligomers of low molecular weight, aliphatic diisocyanates having a molar mass of 140 to 278 g/mol; D) optionally catalysts; E) optionally salts of weak acids, the corresponding free acids of which have a pKA in water at 25° C. of ?3.0 and ?14.

Abstract: The present invention relates to novel aqueous polyurethane dispersions produced using at least two poly(tetramethylene glycol) polyether polyols with different average molar masses and at least two different polyisocyanate components.

Abstract: The present invention relates to a method that includes providing a formulation having an isocyanate-functional prepolymer and a curing component comprising an amino-functional aspartic ester of the general formula (I) applying the formulation to a cell tissue; and curing the formulation such that the loss of blood (haemostatic) or tissue fluids is staunched or leaks in cell tissues are sealed.